Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brent Logan

Showing results (21-30 of 99) with videos related to

Pageof 10
Sort By:
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 20, 2008
Use of cost-effectiveness analysis to determine inventory size for a national cord blood bankDavid H Howard, David Meltzer, Craig Kollman, et al.
Nephrology (Carlton, Vic.)|June 17, 2005
Clinical risk factors associated with bleeding after native kidney biopsyGanesh B Shidham, Nauman Siddiqi, Joseph A Beres, et al.
JAMA Oncology|September 27, 2019
Factors Associated With Successful Discontinuation of Immune Suppression After Allogeneic Hematopoietic Cell TransplantationJoseph Pidala, Michael Martens, Claudio Anasetti, et al.
Blood|August 28, 2004
Alpha phenyl-tert-butyl nitrone (PBN) protects syngeneic marrow transplant recipients from the lethal cytokine syndrome occurring after agonistic CD40 antibody administrationMaria Gendelman, Nadine Halligan, Richard Komorowski, et al.
Blood|October 24, 2002
Expression of MUM1/IRF4 correlates with clinical outcome in patients with B-cell chronic lymphocytic leukemiaChung-Che Chang, Jennifer Lorek, Daniel E Sabath, et al.
Archives of Pathology & Laboratory Medicine|February 4, 2003
Expression of p53, c-Myc, or Bcl-6 suggests a poor prognosis in primary central nervous system diffuse large B-cell lymphoma among immunocompetent individualsChung-Che Chang, Bal Kampalath, Christopher Schultz, et al.
Journal of Clinical Immunology|October 18, 2019
Quality of Life of Patients with Wiskott Aldrich Syndrome and X-Linked Thrombocytopenia: a Study of the Primary Immune Deficiency Consortium (PIDTC), Immune Deficiency Foundation, and the Wiskott-Aldrich FoundationAmi J Shah, Robert Sokolic, Brent Logan, et al.
Bone Marrow Transplantation|July 8, 2023
Application of the CIBMTR One Year Survival Outcomes Calculator as a tool for retrospective analysisChristina Cho, Sean Devlin, Molly Maloy, et al.
Biometrical Journal. Biometrische Zeitschrift|May 17, 2018
A cure-rate model for Q-learning: Estimating an adaptive immunosuppressant treatment strategy for allogeneic hematopoietic cell transplant patientsErica E M Moodie, David A Stephens, Shomoita Alam, et al.
The American Journal of Surgical Pathology|April 17, 2004
Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphomaChung-Che Chang, Sara McClintock, Ronald P Cleveland, et al.
Pageof 10

Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 20, 2008
Use of cost-effectiveness analysis to determine inventory size for a national cord blood bankDavid H Howard, David Meltzer, Craig Kollman, et al.
Nephrology (Carlton, Vic.)|June 17, 2005
Clinical risk factors associated with bleeding after native kidney biopsyGanesh B Shidham, Nauman Siddiqi, Joseph A Beres, et al.
JAMA Oncology|September 27, 2019
Factors Associated With Successful Discontinuation of Immune Suppression After Allogeneic Hematopoietic Cell TransplantationJoseph Pidala, Michael Martens, Claudio Anasetti, et al.
Blood|August 28, 2004
Alpha phenyl-tert-butyl nitrone (PBN) protects syngeneic marrow transplant recipients from the lethal cytokine syndrome occurring after agonistic CD40 antibody administrationMaria Gendelman, Nadine Halligan, Richard Komorowski, et al.
Blood|October 24, 2002
Expression of MUM1/IRF4 correlates with clinical outcome in patients with B-cell chronic lymphocytic leukemiaChung-Che Chang, Jennifer Lorek, Daniel E Sabath, et al.
Archives of Pathology & Laboratory Medicine|February 4, 2003
Expression of p53, c-Myc, or Bcl-6 suggests a poor prognosis in primary central nervous system diffuse large B-cell lymphoma among immunocompetent individualsChung-Che Chang, Bal Kampalath, Christopher Schultz, et al.
Journal of Clinical Immunology|October 18, 2019
Quality of Life of Patients with Wiskott Aldrich Syndrome and X-Linked Thrombocytopenia: a Study of the Primary Immune Deficiency Consortium (PIDTC), Immune Deficiency Foundation, and the Wiskott-Aldrich FoundationAmi J Shah, Robert Sokolic, Brent Logan, et al.
Bone Marrow Transplantation|July 8, 2023
Application of the CIBMTR One Year Survival Outcomes Calculator as a tool for retrospective analysisChristina Cho, Sean Devlin, Molly Maloy, et al.
Biometrical Journal. Biometrische Zeitschrift|May 17, 2018
A cure-rate model for Q-learning: Estimating an adaptive immunosuppressant treatment strategy for allogeneic hematopoietic cell transplant patientsErica E M Moodie, David A Stephens, Shomoita Alam, et al.
The American Journal of Surgical Pathology|April 17, 2004
Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphomaChung-Che Chang, Sara McClintock, Ronald P Cleveland, et al.
Pageof 10